MRC1 and adenoma: In one study concerning MMR gene germline mutation carriers, MSI was detected at 44% in low-grade epithelial neoplasia, and 100% in high-grade dysplasiaThe frequency of MSI in LS-related adenoma was 41–80% [17–22], and the risk of MSI was 3.6-fold higher than that of non-carriers.